Rapid Micro Biosystems (RPID) Shares Outstanding (Weighted Average) (2020 - 2026)
Rapid Micro Biosystems' (RPID) quarterly Shares Outstanding (Weighted Average) came in at $45.4 million in Q1 2026, up 3.27% year-on-year from $44.0 million in Q1 2025, and up 1.69% quarter-over-quarter from $44.7 million in Q4 2025.
Rapid Micro Biosystems (RPID) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $45.4 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $45.4 million, up 3.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.4 million (up 3.27% YoY), and the FY2025 annual result was $44.7 million, up 2.53% from the prior year.
- Shares Outstanding (Weighted Average) came in at $45.4 million for Q1 2026 at Rapid Micro Biosystems, up from $44.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.4 million in Q1 2026 to a low of $42.2 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $43.2 million (2024), against an average of $43.5 million.
- Across the five-year window, Shares Outstanding (Weighted Average) soared 6479.33% in 2022 and increased 1.01% in 2024, its largest moves.
- Rapid Micro Biosystems' Shares Outstanding (Weighted Average) stood at $42.5 million in 2022, then climbed by 1.34% to $43.0 million in 2023, then advanced by 1.28% to $43.6 million in 2024, then gained by 2.53% to $44.7 million in 2025, then gained by 1.69% to $45.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $45.4 million (Q1 2026), $44.7 million (Q4 2025), and $44.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Rapid Micro Biosystems | 77.24 Mn | 54.29 Mn | 371,000.00 | 45.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.43 Mn |
| Dec 31, 2025 | 44.68 Mn |
| Sep 30, 2025 | 44.53 Mn |
| Jun 30, 2025 | 44.65 Mn |
| Mar 31, 2025 | 43.99 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 43.67 Mn |
| Jun 30, 2024 | 43.62 Mn |
| Mar 31, 2024 | 43.25 Mn |
| Dec 31, 2023 | 43.02 Mn |
| Sep 30, 2023 | 42.99 Mn |
| Jun 30, 2023 | 43.06 Mn |
| Mar 31, 2023 | 42.81 Mn |
| Dec 31, 2022 | 42.45 Mn |
| Sep 30, 2022 | 42.52 Mn |
| Jun 30, 2022 | 42.35 Mn |
| Mar 31, 2022 | 42.20 Mn |
| Dec 31, 2021 | 19.78 Mn |
| Sep 30, 2021 | 35.32 Mn |
| Jun 30, 2021 | 668,180.00 |